(Q48473609)

11 February 2018

title

Dual effects of rifampin on the pharmacokinetics of atrasentan (English)

1 reference

11 February 2018

1 reference

1 reference

Hao Xiong

1

1 reference

11 February 2018

Robert A Carr

2

1 reference

11 February 2018

Charles S Locke

3

1 reference

11 February 2018

David A Katz

4

1 reference

11 February 2018

Ramanuj Achari

5

1 reference

11 February 2018

Thao T Doan

6

1 reference

11 February 2018

Perry Wang

7

1 reference

11 February 2018

James R Jankowski

8

1 reference

11 February 2018

Darryl J Sleep

9

1 reference

11 February 2018

publication date

1 April 2007

1 reference

11 February 2018

The Journal of Clinical Pharmacology

published in

1 reference

11 February 2018

volume

47

1 reference

11 February 2018

issue

4

1 reference

11 February 2018

page(s)

423-429

1 reference

11 February 2018

The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Atrasentan: a novel and rationally designed therapeutic alternative in the management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: safety and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Atrasentan: targeting the endothelin axis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

High-throughput determination of atrasentan in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Rifampin decreases the plasma concentrations and effects of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

The effect of gemfibrozil on the pharmacokinetics of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Inhibition of Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake Is the Major Determinant in the Pharmacokinetic Interaction between Bosentan and Cyclosporin A in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Cyclosporine markedly raises the plasma concentrations of repaglinide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

Pharmacokinetic interactions with rifampicin : clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270007299928

21 January 2018

Identifiers

DOI

10.1177/0091270007299928

1 reference

11 February 2018

1 reference

11 February 2018